Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Return on Assets (2020 - 2025)

Historic Return on Assets for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to 0.43%.

  • BioScience Health Innovations' Return on Assets rose 3100.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.18% for FY2024, which is 42000.0% up from last year.
  • BioScience Health Innovations' Return on Assets amounted to 0.43% in Q3 2025, which was up 3100.0% from 0.55% recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' Return on Assets registered a high of 0.55% during Q2 2025, and its lowest value of 17.66% during Q2 2021.
  • Over the past 5 years, BioScience Health Innovations' median Return on Assets value was 1.89% (recorded in 2024), while the average stood at 2.88%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -73100bps in 2021, then surged by 159100bps in 2022.
  • BioScience Health Innovations' Return on Assets (Quarter) stood at 0.67% in 2021, then tumbled by -560bps to 4.4% in 2022, then surged by 39bps to 2.67% in 2023, then surged by 105bps to 0.13% in 2024, then skyrocketed by 218bps to 0.43% in 2025.
  • Its Return on Assets was 0.43% in Q3 2025, compared to 0.55% in Q2 2025 and 0.5% in Q1 2025.